David J. Benjamin, MD
@DavidBenjaminMD
Followers
586
Following
6K
Media
59
Statuses
193
Medical oncologist and researcher with interests in genitourinary cancers and health policy. Tweets are my own views, and are not medical advice.
Orange County, CA
Joined April 2021
Was a pleasure to talk with @RinaNakanoTV of @kcalnews @CBSNews about our @JCOOP_ASCO publication on cancer's portrayal in #movies. Several aspects including #cancer type, treatment and prognosis significantly diverge from reality. Link (video):
1
2
34
Thank you @CancerTodayMag @AACR for featuring our recent @myESMO Real World Data & Digital Oncology study on the portrayal of cancer in public figures in news stories. The public should be cognizant that many news articles lack pertinent details on an individual's diagnosis,.
#ICYMI: What you don’t know about celebrity cancer stories can cause confusion about your own risks or treatment.
2
4
11
RT @OncLive: @DavidBenjaminMD of @hoaghealth, discusses how he uses real-world data to supplement clinical trial results in urothelial carc….
0
1
0
RT @OncLive: Real-World Data Help Fill the Gaps Left by Clinical Trial Results in Urothelial Carcinoma @DavidBenjaminMD #blcsm
https://t.co….
0
2
0
Is the field of genitourinary oncology pivoting away from precision medicine -- and towards imprecision?. In @BJUIjournal, @ArashRezazadeh6 and I cite two recent examples of TALAPRO-2 (for metastatic hormone resistant prostate cancer) and EV-302 (for advanced urothelial
BREAKING: The FDA’s ODAC deemed the results from TALAPRO-2 insufficient to conclude a favorable benefit-risk profile for adding talazoparib to enzalutamide in non-HRRm #mCRPC in an 8 to 0 vote.
3
11
27
RT @JoanaMarinhOnc: RWE is crucial for our daily clinical practice! What insightful discussions on mUC treatments! Balancing QoL with effi….
0
5
0
Congratulations to my mentor @ArashRezazadeh6 on receiving the 2025 @UCIMedSchool Faculty Mentor of the Year Award!. There is no more deserving individual I know who mentors faculty and trainees across multiple specialities and institutions. Fortunate and grateful for your
4
3
35
RT @OncNewsCentral: @TheLancetOncol Comment: As cancer therapies evolve, sexual & reproductive #Toxicity remains underreported. Experts lik….
0
1
0
Is the field of oncology overlooking sexual health and reproductive toxicities from cancer therapies?. In @TheLancetOncol, @DrMarkLythgoe and I highlight two recent examples, and call for improved monitoring & reporting in clinical trials. Many thanks to the editorial team for
1
9
26
RT @DrMarkLythgoe: 🧨Great to be editors pick in @TheLancetOncol this month for our comment. highlighting Sexual health and reproductive t….
0
5
0
How many genitourinary medical oncologists are in the US, and where (region, practice setting, etc.) do they practice?. In @urogoldjournal, we find that there are a total of 451 GU medical oncologists in the US, most of whom are men (72.5%). The majority of GU medical
1
9
27
RT @montypal: One of the highlights of #SoCalGU25 was our inaugural poster session. Congrats to our poster sessions winners, #DrFarzadTeymo….
0
13
0
RT @VPrasadMDMPH: Our paper is out: I found this interesting .Some cancers celebs are more likely to admit to having than others. Above the….
0
2
0
Does reading an article about a public figure with cancer leave you with more uncertainty than clarity?. In @myESMO Real World Data and Digital Oncology, we review news articles about public figures with cancer from 2010 to 2020. Our study found that most articles lack pertinent
6
8
32
RT @urotoday: State of the Genitourinary Medical Oncology Workforce in the United States, 2024. Presentation by @DavidBenjaminMD @hoaghealt….
0
4
0
RT @drenriquegrande: Individualizing first-line treatment for advanced urothelial carcinoma: A favorable dilemma for patients and physician….
0
11
0
RT @PGrivasMDPhD: Looking forward to reviewing this editorial. Timely since TROPiCS04 paper coming very soon, stay tuned :-).@tompowles1 @U….
0
2
0
Why did sacituzumab govitecan fail in the TROPiCS-04 study for advanced urothelial carcinoma?. In @EurUrolOncol, we discuss the potential roles of G-CSF, dosing approaches, and differences in patient population compared to the TROPHY-U-01 trial. Link:
3
14
27
RT @drenriquegrande: Amazing piece of work by @DavidBenjaminMD, @DrRanaMcKay and colls. with impact in daily practice: urachal tumors appr….
0
11
0
We also provide further insight into the tumor microenvironment of urachal cancer, evaluate markers of responsiveness to immunotherapy, and more. Truly a pleasure to work with our colleagues at @carisls and GU leaders @DrRanaMcKay and @ArashRezazadeh6 on this study! (2/2).
1
1
2
Is it time to re-classify urachal cancer as a GI rather than a GU malignancy?. In @Nature_NPJ Precision Oncology, we show the genomic profile of this rare cancer is more similar to colorectal than bladder cancer. (1/2). Link:
2
18
63